T-One Therapeutics S.r.l.
PrivateLast Round
Seed
Sep 21, 2022
Total Funding Raised
$2.48M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
T-One Therapeutics S.r.l. is a biotechnology company that develops innovative RNA-based immunotherapies targeting LINE1 elements to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-One Therapeutics S.r.l. Comparables
Compare T-One Therapeutics S.r.l. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CheckmAb S.r.l. | 74% | |
| HAYA Therapeutics | 68% | |
| Enara Bio | 64% |
T-One Therapeutics S.r.l. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 21, 2022 |
T-One Therapeutics S.r.l. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Utopia SIS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 68% MoM.
- Apr 5, 2026
Monthly visitors increased 77% MoM.
T-One Therapeutics S.r.l. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about T-One Therapeutics S.r.l.'s valuation, stock price, and market status.
Is T-One Therapeutics S.r.l. a public or private company?
T-One Therapeutics S.r.l. is a private company.
What is the current stock price of T-One Therapeutics S.r.l.?
T-One Therapeutics S.r.l. is a private company with no public stock price. No recent secondary market data is available.
How much is T-One Therapeutics S.r.l. worth (valuation)?
Valuation information for T-One Therapeutics S.r.l. is not publicly available.
Can I buy T-One Therapeutics S.r.l. stock?
T-One Therapeutics S.r.l. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was T-One Therapeutics S.r.l.'s last funding round?
T-One Therapeutics S.r.l.'s most recent funding round was Seed on September 21, 2022.
Who are the main investors in T-One Therapeutics S.r.l.?
Key investors in T-One Therapeutics S.r.l. include Utopia SIS.
Will T-One Therapeutics S.r.l. IPO soon?
No public IPO plans have been announced for T-One Therapeutics S.r.l..
How can I track T-One Therapeutics S.r.l. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor T-One Therapeutics S.r.l.'s secondary market activity and sign up for updates.